# The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells

**Authors:** Jacob Mora, Iu Raïch, Valentina Ugalde, Gemma Navarro, Carolina Prado, Pia M. Vidal, Pedro Leal, Alexandra Espinoza, Moting Liu, Rinse Weersma, Ranko Gacesa, Marcela A. Hermoso, Rafael Franco, Rodrigo Pacheco

PMC · DOI: 10.3390/ijms262010069 · 2025-10-16

## TL;DR

The study shows that a dopamine receptor pair in the gut controls immune cells that reduce inflammation, and disrupting this pair worsens gut inflammation.

## Contribution

The novel finding is that the Drd2:Drd3 dopamine receptor heteromer regulates Treg cell activity and recruitment during gut inflammation.

## Key findings

- Mice with Drd2-deficient T-cells developed more severe colitis.
- Drd2 stimulation enhances Treg suppressive activity and recruitment to the gut.
- Disrupting the Drd2:Drd3 heteromer impairs Treg function and gut recruitment.

## Abstract

Since colonic dopamine levels are markedly reduced during inflammatory bowel disease (IBD), we investigated how dopamine affects regulatory T-cells (Treg), which critically limit gut inflammation. Previously, we showed that the stimulation of the high-affinity dopamine receptor D3 (Drd3) impairs suppressive Treg activity and limits their recruitment into the colon upon gut inflammation. Here we study the role of the low-affinity dopamine receptor Drd2 in Treg. We find that mice harbouring Drd2-deficient T-cells developed more severe colitis induced by dextran sodium sulphate. The stimulation of Drd2 potentiated the suppressive Treg activity and increased their ability to reach the colonic tissue. A transcriptomic analysis of intestinal mucosa from IBD patients revealed an association with increased DRD3 and reduced DRD2 expression. Bioluminescence resonance energy transfer assays revealed that Drd2 and Drd3 form a heteromer. An in situ proximity ligation assay indicated that the Drd2:Drd3 heteromer was expressed on colonic Treg, and its expression was increased upon inflammation. Using peptides analogous to the transmembrane (TM) segments from Drd2 and Drd3 in bimolecular fluorescence complementation assays, we found TM peptides able to disassemble this heteromer. The heteromer disassembly dampened the suppressive Treg activity and impaired the recruitment of Treg into the colon upon inflammation. Our findings indicate that the Drd2:Drd3 heteromer constitutes a dopamine sensor that regulates suppressive Treg activity and their colonic recruitment.

## Linked entities

- **Genes:** DRD3 (dopamine receptor D3) [NCBI Gene 1814], DRD2 (dopamine receptor D2) [NCBI Gene 1813]
- **Diseases:** inflammatory bowel disease (MONDO:0005265), colitis (MONDO:0005292)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** DRD2 (dopamine receptor D2) [NCBI Gene 1813] {aka D2DR, D2R}, DRD3 (dopamine receptor D3) [NCBI Gene 1814] {aka D3DR, ETM1, FET1}
- **Diseases:** colitis (MESH:D003092), gut inflammation (MESH:D007249), IBD (MESH:D015212)
- **Chemicals:** dextran sodium sulphate (-), dopamine (MESH:D004298)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12563322/full.md

---
Source: https://tomesphere.com/paper/PMC12563322